Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney

Kidney International

Volumn 51, Issue 3, 1997, Pages 711-721

  Van Kooten, Cees ^a   Gerritsma, Jort S J ^b   Paape, Marion E ^b   Van Es, Leendert A ^b   Banchereau, Jacques ^b   Daha, Mohamed R ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CHEMOKINE; CYTOKINE;

ANIMAL CELL; ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030932562     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.102     Document Type: Article

References (78)

1. RISDON RA, SLOPER JC, DE WARDENER HE: Relationship between renal function and histological changes found in renal biopsy specimen from patients with persistent glomerular nephritis. Lancet 2:363-366, 1968
2. BOHLE A, WEHRMANN M, BOGENSCHUTZ O, BATZ C, VOGL W, SCHMITT H, MULLER CA, MULLER GA: The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract 188:908-924, 1992
3. BOHLE A, MULLER GA, WEHRMAN M, MACKENSEN-HAEN S, XIAO JC: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int 49(Suppl 49):S2-S9, 1996
4. STRUTZ F, NEILSON EG: The role of lymphocytes in the progression of interstitial disease. Kidney Int 45(Suppl 45):S106-S110, 1994
5. OKADA H, STRUTZ F, DANOFF TM, NEILSON EG: Possible pathogenesis of renal fibrosis. Kidney Int 49(Suppl 49):S37-S38, 1996
6. BOUCHER A, DROZ D, ADAFER E, LAURE-HELENE N: Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int 29:1043-1049, 1986
7. BOLTON WK, INNES DJ, STURGILL BC, KAISER DL: T cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathologic correlations. Kidney Int 32:1552-1556, 1987
8. HOOKE HH, GEE DC, ATKINS RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964-972, 1987
9. MARKOVIC-LIPKOVSKI J, MULLER CA, RISLER T, BOHLE A, MULLER GA: Association of glomerular and interstitial mononuclear leukocytes with different forms of glomerulonephritis. Nephrol Dial Transplant 5:10-17, 1990
10. BEN-BARUCH A, MICHIEL DF, OPPENHEIM JJ: Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem 270:11703-11706, 1995
11. FURIE MB, RANDOLPH GJ: Chemokines and tissue injury. Am J Pathol 146:1287-1301, 1995
12. SCHMOUDER RL, STRIETER RM, WIGGINS RC, CHENSUE SW, KUNKEL SL: In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int 41:191-198, 1992
13. GERRITSMA JSJ, HIEMSTRA PS, GERRITSEN AF, PRODJOSUDJADI W, VERWEIJ CL, VAN ES LA, DAHA MR: Regulation and production of IL-8 by human proximal tubular epithelial cells in vitro. Clin Exp Immunol 103:289-294, 1996
14. SCHMOUDER RL, STRIETER RM, KUNKEL SL: Interferon-gamma regulation of human renal cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int 44:43-49, 1993
15. PRODJOSUDJADI W, GERRITSMA JSJ, KLAR-MOHAMED N, GERRITSEN AF, BRUIJN JA, DAHA RD, VAN ES LA: Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by proximal tubular epithelial cells. Kidney Int 48:1477-1486, 1995
16. PRODJUSODJADI W, GERRITSMA JSJ, VAN ES LA, DAHA MR, BUIJN JA: Monocyte chemoattractant protein-1 in normal and diseased human kidneys: An immunohistochemical analysis. Clin Nephrol 44:148-155, 1995
17. PATTISON J, NELSON PJ, HUIE P, VON LEUTTICHA I, FARSHID G, SIBLEY RK, KRENSKY AM: RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 343:209-211, 1994
18. HEEGER P, WOLF G, MEYERS C, SUN MJ, O'FARREL SC, KRENSKY AM, NEILSON EG: Isolation and characterization of cDNA from renal tubular epithelium encoding murine RANTES. Kidney Int 41:220-225, 1992
19. REMUZZI G: Abnormal protein traffic through the glomerular barrier induces proximal tubular dysfunction and causes renal injury. Curr Opin Nephrol Hypertens 4:339-342, 1995
20. STAMENKOVIC I, CLARK EA, SEED B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403-1410, 1989
21. ARMITAGE RJ, FANSLOW WC, STROCKBINE L, SATO TA, CLIFFORD KN, MACDUFF BM, ANDERSON DM, GIMPEL SD, DAVIS-SMITH T, MALISZEWSKI CR, CLARK EA, SMITH CA, GRABSTEIN KH, COSMAN D, SPRIGGS MK: Molecular and biological characterization of a murine ligand for CD40. Nature 357:80-82, 1992
22. BANCHEREAU J, BAZAN F, BLANCHARD D, BRIERE F, GALIZZI JP, VAN KOOTEN C, LIU YJ, ROUSSET F, SAKLAND S: The CD40 antigen and its ligand. (Review) Annu Rev Immunol 12:881-922, 1994
23. CLARK EA, LEDBETTER JA: How B and T cells talk to each other. (Review) Nature 367:425-428, 1994
24. SMITH CA, FARRAH T, GOODWIN RG: The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation and death. Cell 76:959-962, 1994
25. VAN KOOTEN C, BANCHEREAU J: CD40-CD40 ligand: A multifunctional receptor-ligand pair. Adv Immunol 61:1-77, 1996
26. CALLARD RE, ARMITAGE RJ, FANSLOW WC, SPRIGGS MK: CD40 ligand and its role in X-linked hyper-IgM syndrome. (Review) Immunol Today 14:559-564, 1993
27. KROCZEK RA, GRAF D, BRUGNONI D, GILIANI S, KORTHUER U, UGAZIO A, SENGER G, MAGES HW, VILLA A, NOTARANGELO LD: Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)." (Review) Immunol Rev 138:39-59, 1994
28. ALDERSON MR, ARMITAGE RJ, TOUGH TW, STROCKBINE L, FANSLOW WC, SPRIGGS MK: CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178:669-674, 1993
29. WAGNER DJ, STOUT RD, SUTTLES J: Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol 24:3148-3154, 1994
30. PEGUET-NAVARRO J, DALBIEZ-GAUTHIER C, RATTIS FM, VAN KOOTEN C, BANCHEREAU J, SCHMITT D: Functional expression of CD40 antigen on human epidermal Langerhans cells. J Immunol 155:4241-4247, 1995
31. CAUX C, MASSACRIER C, VANBERVLIET B, DUBOIS B, VAN KOOTEN C, DURAND I, BANCHEREAU J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263-1272, 1994
32. YELLIN MJ, BRETT J, BAUM D, MATSUSHIMA A, SZABOLCS M, STERN D, CHESS L: Functional interactions of T cells with endothelial cells: The role of CD40L-CD40-mediated signals. J Exp Med 182:1857-1864, 1995
33. KARMANN K, HUGHES CC, SCHECHNER J, FANSLOW WC, POBER JS: CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 92:4342-4346, 1995
34. HOLLENBAUGH D, MISCHEL-PETTY N, EDWARDS CP, SIMON JC, DENFELD RW, KIENER PA, ARUFFO A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 182:33-40, 1995
35. YELLIN MJ, WINIKOFF S, FORTUNE SM, BAUM D, CROW MK, LEDERMAN S, CHESS L: Ligation of CD40 on flbroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leuk Biol 58:209-216, 1995
36. GALY AHM, SPITS H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149:775-782, 1992
37. KOHO H, PAULIE S, BEN-AISSA H, JONSDOTTIR I, HANSSON Y, LUNDBLAD ML, PERLMAN P: Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence. Cancer Immunol Immunother 17: 165-172, 1984
38. YOUNG LS, DAWSON CW, BROWN KW, RICKINSON AB: Identification of a human epithelial cell surface protein sharing an epitope with the C3 days/Epstein-barr virus receptor molecule on B lymphocytes. Int J Cancer 43:786-794, 1989
39. GARRONE P, NEIDHARDT EM, GARCIA E, GALIBERT L, VAN KOOTEN C, BANCHEREAU J: Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med 182:1265-1273, 1995
40. TAKEBE Y, SEIKI M, FUJISAWA J-I, HOY P, YOKOTA K, ARAI K-I, YOSHIDA M, ARAI N: SRα promotor: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus Type I long terminal repeat. Mol Cell Biol 8:466-472, 1988
41. SEELEN MA, BROOIMANS RA, VAN DER WOUDE FJ, VAN ES LA, DAHA MR: IFN-gamma mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. Kidney Int 44:50-57, 1993
42. DETRISAC CJ, SENS MA, GARVIN AJ, SPICER SS, SENS DA: Tissue culture of human kidney epithelial cells of proximal tubule origin. Kidney Int 25:383-390, 1984
43. VALLE A, ZUBER CE, DEFRANCE T, DJOSSOU O, DE RIE M, BANCHEREAU J: Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 19:1463-1467, 1989
44. CLARK EA, LEDBETTER JA: Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA 83:4494-4498, 1986
45. HERMANN P, VAN KOOTEN C, GAILLARD C, BANCHEREAU J, BLANCHARD D: CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation. Eur J Immunol 25:2972-2977, 1995
46. RETERINK TJF, LEVARHT EWN, KLAR-MOHAMED N, VAN ES LA, DAHA MR: Transforming growth factor-beta 1 (TGF-β1) down-regulates IgA Fc-receptor (CD89) expression on human monocytes. Clin Exp Immunol 103:161-166, 1996
47. RAAF AK, VAN DE CORPUT MP, VERVENNE RA, VAN GIJLSWIJK RP, TANKE HJ, WIEGANT J: Ultra-sensitive FISH using peroxidase-mediated deposition of biotin- or fluorochrome tyramides. Hum Mol Genet 4:529-534, 1995
48. ABE S, AMAGASAKI Y, IYORI S, KONISHI K, KATO E, SAKAGUCHI H: Significance of tubulointerstitial lesions in biopsy specimens of glomerulonephritic patiens. Am J Nephrol 9:30-37, 1989
49. CAMERON JS: Tubular and interstitial factors in the progression of glomerulonephritis. (Review) Pediatr Nephrol 6:292-303, 1992
50. MAIN IW, ATKINS RC: The role of T-cells in inflammatory kidney disease. (Review) Curr Opin Nephrol Hypertens 4:354-358, 1995
51. BROOIMANS RA, STEGMAN APA, VAN DORP WT, VAN DER WOUDE FJ, VAN ES LA, DAHA MR: Interleukin 2 mediates stimulation of complement C3 by human proximal tubular epithelial cells (PTEC). J Clin Invest 88:379-384, 1991
52. GERRITSMA JSJ, GERRITSEN AF, VAN KOOTEN C, VAN ES LA, DAHA MR: Interleukin-1-alpha enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro. Molec Immunol (in press)
53. SCHALL TJ, BACON K, TOY KJ, GOEDDEL DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669-671, 1990
54. MARFAING-KOKA A, DEVERGNE O, GORGONE G, PORTIER A, SCHALL TJ, GALANAUD P, EMILIE D: Regulation of the production of the RANTES chemokine by endothelial cells. J Immunol 154:1870-1878, 1995
55. STELLATO C, BECK LA, GORGONE GA, PROUD D, SCHALL TJ, ONO SJ, LICHTENSTEIN LM, SCHLEIMER RP: Expression of the chemokine RANTES by a human bronchial epithelial cell line. J Immunol 155:410-418, 1995
56. SCHALL TJ, JONGSTRA J, DYER BJ, JORGENSEN J, CLAYBERGER C, DAVIS MM, KRENSKY AM: A human T cell specific molecule is a member of a new gene family. J Immunol 141:1018-1025, 1988
57. BACON KB, PREMACK BA, GARDNER P, SCHALL TJ: Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269: 1727-1730, 1995
58. VAN DER WOUDE FJ, SCHRAMA E, VAN ES LA, CLAAS FJ, DAHA MR: The role of unconventional alloantigens in interstitial and vascular rejection after renal transplantation. (Review) Transplant Immunol 2:271-277, 1994
59. VAN DER WOUDE FJ, DECKERS JGM, MALLAT MJK, YARD BA, SCHRAMA E, VAN SAASE JLCM, DAHA MR: Tissue antigens in tubulointerstitial and vascular rejection. Kidney Int 48(Suppl 52):S11-S13, 1995
60. SINGER GG, YOKOYAMA H, BLOOM RD, JEVNIKAR AM, NABAVI N, KELLEY VR: Stimulated renal tubular epithelial cells induce anergy in CD4+ T cells [see comments]. Kidney Int 44:1030-1035, 1993
61. HAGERTY DT, ALLEN PM: Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol 148:2324-2330, 1992
62. YOKOYAMA H, ZHENG X, STROM TB, KELLEY VR: B7+ transfectant tubular epithelial cells induce T cell anergy, ignorance or proliferation. Kidney Int 45:1105-1112, 1994
63. BUHLMANN JE, FOY TM, ARUFFO A, CRASSI KM, LEDBETTER JA, GREEN WR, XU JC, SHULTZ LD, ROOPESIAN D, FLAVELL RA, FAST L, NOELLE RJ, DURIE FH: In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2:645-653, 1995
64. GREWAL IS, XU J, FLAVELL RA: Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617-620, 1995
65. LARSEN CP, ELWOOD ET, ALEXANDER DZ, RITCHIE SC, HENDRIX R, TUCKER-BURDEN C, CHO HR, ARUFFO A, HOLLENBAUGH D, LINSLEY PS, WINN KJ, PEARSON TC: Long-term acceptance of skin and cardia allografts after blocking CD40 and CD28 pathways. Nature 381:434-438, 1996
66. SHIPP MA, LOOK AT: Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key! Blood 82:1052-1070, 1993
67. VAN DEN EERTWEGH AJ, NOELLE RJ, ROY M, SHEPHERD DM, ARUFFO A, LEDBETTER JA, BOERSMA WJ, CLAASSEN E: In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J Exp Med 178:1555-1565, 1993
68. LEDERMAN S, YELLIN MJ, INGHIRAMI G, LEE JJ, KNOWLES DM, CHESS L: Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 149:3817-3826, 1992
69. CASAMAYOR-PELLEJA M, KAHN M, MACLENNAN ICM: A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med 181:1293-1301, 1995
70. YELLIN MJ, SIPPEL K, INGHIRAMI G, COVEY LR, LEE JJ, SINNING J, CLARK EA, CHESS L, LEDERMAN S: CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function. J Immunol 152:598-608, 1994
71. VAN KOOTEN C, GAILLARD C, GALIZZI JP, HERMANN P, FOSSIEZ F, BANCHEREAU J, BLANCHARD D: B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol 24:787-792, 1994
72. CHALUPNY NJ, PEACH R, HOLLENBAUCH D, LEDBETTER JA, FARR AG, ARUFFO A: T-cell activation molecule 4-1BB binds to extracellular matrix proteins. Proc Natl Acad Sci USA 89:10360-10364, 1992
73. GOODWIN RG, DIN WS, DAVIS-SMITH T, ANDERSON DM, GIMPEL SD, SATO TA, MALISZEWSKI CR, BRANNAN CI, COPELAND NG, JENKINS NA, FARRAH T, ARMITAGE RJ, FANSLOW WC, SMITH CA: Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokies with homology to tumor necrosis factor. EurJ Immunol 23:2631-2641, 1993
74. DURIE FH, FAVA RA, FOY TM, ARUFFO A, LEDBETTER JA, NOELLE RJ: Prevention of collagen-induced arthritis with an antibody to gp39. the ligand for CD40. Science 261:1328-1330, 1993
75. DURIE FH, ARUFFO A, LEDBETTER J, CRASSI KM, GREEN WR, FAST LD, NOELLE RJ: Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest 94:1333-1338, 1994
76. PARKER DC, GREINER DL, PHILLIPS NE, APPEL MC, STEELE AW, DURIE FH, NOELLE RJ, MORDES JP, ROSSINI AA: Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 92:9560-9564, 1995
77. MOHAN C, SHI Y, LAMAN JD, DATTA SK: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470-1480, 1995
78. BIANCONE L, ANDRES G, AHN H, DEMARTINO C, STAMENKOVIC I: Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis. Kidney Int 48:458-468, 1995